CardioNerds
Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!
Advertisement
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy.
The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI.
The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD.
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
The NOTION 3 trial contributes important data to the ongoing debate about the role of PCI before TAVI in patients with CAD.
Dr. Amit Goyal details the bRIGHT study, which offers a valuable glimpse into the performance of the Abbott TriClip device.
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
Treatment-related early increase in serum transthyretin levels are associated with reduced CV-related hospitalizations.
A study uncovered surprising findings regarding the presence and nature of transthyretin in stenotic aortic valves.
A study investigated the prevalence and implications of ATTR-CA across different heart failure phenotypes.
A case series explored the impact of possessing more than 1 pathogenic variant of the TTR gene on the severity of ATTR.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.